summary,PseudoDualFlexiSimulations-method {crmPack} | R Documentation |
Summary for Pseudo Dual responses simulations given a pseudo DLE model and the Flexible efficacy model.
Description
Summary for Pseudo Dual responses simulations given a pseudo DLE model and the Flexible efficacy model.
Usage
## S4 method for signature 'PseudoDualFlexiSimulations'
summary(
object,
trueDLE,
trueEff,
targetEndOfTrial = 0.3,
targetDuringTrial = 0.35,
...
)
Arguments
object |
the |
trueDLE |
a function which takes as input a dose (vector) and returns the true probability of DLE (vector) |
trueEff |
a vector which takes as input the true mean efficacy values at all dose levels (in order) |
targetEndOfTrial |
the target probability of DLE that are used at the end of a trial. Default at 0.3. |
targetDuringTrial |
the target probability of DLE that are used during the trial. Default at 0.35. |
... |
Additional arguments can be supplied here for |
Value
an object of class PseudoDualSimulationsSummary
Examples
##If DLE and efficacy responses are considered in the simulations and the 'EffFlexi' class is used
## we need a data object with doses >= 1:
data <- DataDual(doseGrid=seq(25,300,25))
##First for the DLE model
##The DLE model must be of 'ModelTox' (e.g 'LogisticIndepBeta') class
DLEmodel <- LogisticIndepBeta(binDLE=c(1.05,1.8),
DLEweights=c(3,3),
DLEdose=c(25,300),
data=data)
## for the efficacy model
Effmodel<- EffFlexi(Eff=c(1.223, 2.513),Effdose=c(25,300),
sigma2=c(a=0.1,b=0.1),sigma2betaW=c(a=20,b=50),smooth="RW2",data=data)
##specified the next best
mynextbest<-NextBestMaxGainSamples(DLEDuringTrialtarget=0.35,
DLEEndOfTrialtarget=0.3,
TDderive=function(TDsamples){
quantile(TDsamples,prob=0.3)},
Gstarderive=function(Gstarsamples){
quantile(Gstarsamples,prob=0.5)})
##The increments (see Increments class examples)
## 200% allowable increase for dose below 300 and 200% increase for dose above 300
myIncrements<-IncrementsRelative(intervals=c(25,300),
increments=c(2,2))
##cohort size of 3
mySize<-CohortSizeConst(size=3)
##Stop only when 10 subjects are treated:
## very low sample size is just for illustration here
myStopping <- StoppingMinPatients(nPatients=10)
##Specified the design
design <- DualResponsesSamplesDesign(nextBest=mynextbest,
cohortSize=mySize,
startingDose=25,
model=DLEmodel,
Effmodel=Effmodel,
data=data,
stopping=myStopping,
increments=myIncrements)
##specified the true DLE curve and the true expected efficacy values at all dose levels
myTruthDLE<- function(dose)
{ DLEmodel@prob(dose, phi1=-53.66584, phi2=10.50499)
}
myTruthEff<- c(-0.5478867, 0.1645417, 0.5248031, 0.7604467,
0.9333009 ,1.0687031, 1.1793942 , 1.2726408 ,
1.3529598 , 1.4233411 , 1.4858613 , 1.5420182)
##specify the options for MCMC
#For illustration purpose, we use 10 burn-in and generate 100 samples
options<-McmcOptions(burnin=10,step=1,samples=100)
##The simulation
##For illustration purpose only 1 simulation is produced (nsim=1).
mySim<-simulate(object=design,
args=NULL,
trueDLE=myTruthDLE,
trueEff=myTruthEff,
trueSigma2=0.025,
trueSigma2betaW=1,
nsim=1,
seed=819,
parallel=FALSE,
mcmcOptions=options)
##summarize the simulation results
summary(mySim,
trueDLE=myTruthDLE,
trueEff=myTruthEff)
[Package crmPack version 1.0.6 Index]